Progressive
PGR NYSE Property & Casualty Insurance Financials FY2016βFY2025
Progressive's revenue rose 16.3% to $87.7 billion in fiscal 2025. Its net margin was 12.9%, up from 11.2% a year earlier. Free cash flow was $17.2 billion, up 15.9%. It paid out $2.9 billion in dividends and buybacks, 17% of free cash flow.
About these figures. Debt is the total of Progressive's long-term and short-term debt as its filings tag it.
What Progressive does
No business description yet.
- Legal name
- PROGRESSIVE CORP/OH/
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000080661-26-000086
0000080661
Revenue and margins
Progressive had $87.7B of revenue in fiscal 2025, up 16.3% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 30.4% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $17.2B in fiscal 2025, 19.6% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Progressive returned $2.9B to shareholders in fiscal 2025, 17% of free cash flow. The diluted share count rose 0.1%.
Value Progressive yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of $3.2B and divides by 588.1M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 11.4x Β· peers 9.7x Β· sector 13.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Progressive can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.1B | $3.1B | $1.9B | $769M | $10.1B |
| Debt incl. finance leases | $4.9B | $6.4B | $6.9B | $6.9B | $6.9B |
| Net debt / EBITDA | 0.8x | 2.2x | 0.9x | 0.5x | β0.2x |
| Debt / equity | 0.3x | 0.4x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 20.3x | 4.8x | 19.3x | 39.4x | 52.2x |
| Total assets | $71.1B | $75.5B | $88.7B | $105.7B | $123.0B |
| Total liabilities | $52.9B | $59.6B | $68.4B | $80.2B | $92.7B |
| Shareholders' equity | $18.2B | $15.9B | $20.3B | $25.6B | $30.3B |
| Net debt (β = net cash) | $3.8B | $3.3B | $5.0B | $6.1B | β$3.2B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$25.0M
8 insiders
Of sales under plans
94%
$23.4M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Steven BrozChief Information Officer | Sold plan | 1,225 | $204.29 | $0.3M | Form 4 |
| Sep 1, 2026 | Susan Patricia GriffithPresident and CEO, Director | Sold plan | 37,338 | $219.50 | $8.2M | Form 4 |
| Aug 20, 2026 | Steven BrozChief Information Officer | Sold plan | 1,225 | $219.40 | $0.3M | Form 4 |
| Aug 13, 2026 | Lori A NiederstChief Personal Lines Officer | Sold plan | 7,339 | $209.29 | $1.5M | Form 4 |
| Jul 28, 2026 | Andrew J QuiggVP and Chief Financial Officer | Sold plan | 3,499 | $220.00 | $0.8M | Form 4 |
| Jul 27, 2026 | John Jo MurphyClaims President | Sold plan | 8,124 | $212.70 | $1.7M | Form 4 |
| Jul 27, 2026 | Jonathan S. BauerChief Investment Officer | Sold plan | 2,242 | $212.71 | $0.5M | Form 4 |
| Jul 27, 2026 | Karen BailoCommercial Lines President | Sold plan | 8,452 | $212.71 | $1.8M | Form 4 |
| Jul 27, 2026 | Susan Patricia GriffithPresident and CEO, Director | Sold plan | 37,338 | $212.71 | $7.9M | Form 4 |
| Jul 23, 2026 | Steven BrozChief Information Officer | Sold plan | 1,156 | $205.17 | $0.2M | Form 4 |
| Jun 24, 2026 | Jeffrey D KellyDirector | Sold | 7,000 | $216.33 | $1.5M | Form 4 |
| Jun 22, 2026 | Steven BrozChief Information Officer | Sold plan | 1,157 | $204.76 | $0.2M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 9 | β / 9 | β / 9 |
| Accruals ratio | β8.2% | β6.8% | β5.5% |
| Altman Z'' | β | β | β |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Progressive PGR | $133.2B | 16.3% | β | 19.6% | 39.2% | 11.4x | β | |
| Allstate ALL | $65.6B | 5.6% | β | 14.6% | 37.3% | 5.1x | β | Compare β |
| Chubb CB | $140.1B | 6.5% | β | β | 13.6% | 12.6x | β | Compare β |
| Travelers Companies TRV | $83.9B | 5.2% | β | β | 20.1% | 10.5x | β | Compare β |
| Hartford HIG | $37.8B | 6.9% | β | 20.3% | 22.6% | 8.8x | β | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $23.4B | $26.8B | $32.0B | $39.0B | $42.7B | $47.7B | $49.6B | $62.1B | $75.4B | $87.7B |
| Interest expense | $141M | $153M | $167M | $190M | $217M | $219M | $244M | $268M | $279M | $278M |
| Pretax income | $1.5B | $2.1B | $3.2B | $5.2B | $7.2B | $4.2B | $922M | $4.9B | $10.7B | $14.2B |
| Income tax | $414M | $541M | $543M | $1.2B | $1.5B | $859M | $200M | $1.0B | $2.2B | $2.9B |
| Net income | $1.0B | $1.6B | $2.6B | $4.0B | $5.7B | $3.4B | $722M | $3.9B | $8.5B | $11.3B |
| Diluted EPS | $1.76 | $2.72 | $4.42 | $6.72 | $9.66 | $5.66 | $1.18 | $6.58 | $14.40 | $19.23 |
| Diluted shares | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B | 0.59B |
| Cash flow | ||||||||||
| Cash from operations | $2.7B | $3.8B | $6.3B | $6.3B | $6.9B | $7.8B | $6.8B | $10.6B | $15.1B | $17.5B |
| Capital expenditure | $215M | $156M | $266M | $364M | $224M | $244M | $292M | $252M | $285M | $348M |
| Free cash flow | $2.5B | $3.6B | $6.0B | $5.9B | $6.7B | $7.5B | $6.6B | $10.4B | $14.8B | $17.2B |
| Depreciation and amortization | $200M | $236M | $262M | $306M | $332M | $337M | $337M | $299M | $284M | $313M |
| Stock-based compensation | β | β | β | β | β | β | β | $121M | $122M | $132M |
| Acquisitions | $0.0M | $18.1M | $0.0M | $0.0M | $0.0M | $313M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $193M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Dividends paid | $519M | $395M | $655M | $1.6B | $1.6B | $3.7B | $234M | $234M | $674M | $2.9B |
| Dividends and buybacks | $712M | $395M | $655M | $1.6B | $1.6B | $3.7B | $234M | $234M | $674M | $2.9B |
| Balance sheet | ||||||||||
| Cash and short-term investments | $3.8B | $3.1B | $1.9B | $2.0B | $5.3B | $1.1B | $3.1B | $1.9B | $769M | $10.1B |
| Total debt | $3.1B | $3.3B | $4.4B | $4.4B | $5.4B | $4.9B | $6.4B | $6.9B | $6.9B | $6.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Inventory | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Property and equipment, net | $1.2B | $1.1B | $1.1B | $1.2B | $1.1B | $1.1B | $1.0B | $881M | $790M | $783M |
| Total assets | $33.4B | $38.7B | $46.6B | $54.9B | $64.1B | $71.1B | $75.5B | $88.7B | $105.7B | $123.0B |
| Total liabilities | $25.0B | $28.9B | $35.5B | $41.0B | $47.1B | $52.9B | $59.6B | $68.4B | $80.2B | $92.7B |
| Shareholders' equity | $8.0B | $9.3B | $10.8B | $13.7B | $17.0B | $18.2B | $15.9B | $20.3B | $25.6B | $30.3B |
| Margins | ||||||||||
| EBITDA margin | 7.7% | 9.4% | 11.2% | 14.5% | 18.1% | 10.0% | 3.0% | 8.8% | 15.0% | 16.9% |
| Net margin | 4.4% | 5.9% | 8.2% | 10.2% | 13.4% | 7.0% | 1.5% | 6.3% | 11.3% | 12.9% |
| FCF margin | 10.7% | 13.4% | 18.8% | 15.1% | 15.7% | 15.8% | 13.2% | 16.7% | 19.7% | 19.6% |
| Returns | ||||||||||
| Return on capital | 15.5% | 20.4% | 24.2% | 28.1% | 35.4% | 18.0% | 4.4% | 18.5% | 30.5% | 39.2% |
| Return on equity | 13.5% | 18.5% | 26.0% | 32.4% | 37.2% | 19.0% | 4.2% | 21.6% | 37.0% | 40.5% |
| Return on assets | 3.3% | 4.4% | 6.1% | 7.8% | 9.6% | 5.0% | 1.0% | 4.8% | 8.7% | 9.9% |
| Growth | ||||||||||
| Revenue growth | 12.4% | 14.5% | 19.2% | 22.0% | 9.3% | 11.8% | 4.0% | 25.2% | 21.4% | 16.3% |
| Net income growth | β18.7% | 54.4% | 64.3% | 51.8% | 43.7% | β41.3% | β78.5% | 440.6% | 117.3% | 33.4% |
| EPS growth | β18.1% | 54.6% | 62.5% | 52.0% | 43.8% | β41.4% | β79.2% | 457.6% | 118.8% | 33.5% |
| FCF growth | 16.4% | 43.0% | 67.1% | β2.0% | 13.3% | 12.5% | β12.8% | 58.5% | 42.8% | 16.0% |
| Share count change | β0.7% | 0.1% | 0.2% | 0.1% | 0.1% | β0.1% | 0.0% | 0.1% | 0.0% | 0.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | β0.4x | 0.1x | 0.7x | 0.4x | 0.0x | 0.8x | 2.2x | 0.9x | 0.5x | β0.2x |
| Debt / equity | 0.4x | 0.4x | 0.4x | 0.3x | 0.3x | 0.3x | 0.4x | 0.3x | 0.3x | 0.2x |
| Interest coverage | 11.4x | 15.0x | 20.0x | 28.2x | 34.1x | 20.3x | 4.8x | 19.3x | 39.4x | 52.2x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.9% | 0.6% | 0.8% | 0.9% | 0.5% | 0.5% | 0.6% | 0.4% | 0.4% | 0.4% |
| Stock comp / revenue | β | β | β | β | β | β | β | 0.2% | 0.2% | 0.2% |
| Payouts / FCF | 28.3% | 11.0% | 10.9% | 27.9% | 23.2% | 49.8% | 3.6% | 2.3% | 4.5% | 16.7% |
| Quality scores | ||||||||||
| Accruals ratio | β5.4% | β6.0% | β8.6% | β4.5% | β2.0% | β6.5% | β8.4% | β8.2% | β6.8% | β5.5% |
Source: SEC EDGAR XBRL filings (CIK 0000080661). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.